跳至主要内容
临床试验/ISRCTN12308164
ISRCTN12308164已完成1 期

Clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial

Royal National Hospital for Rheumatic Diseases (UK)0 个研究点目标入组 180 人开始时间: 2015年12月15日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Patients had to meet the modified New York criteria for the diagnosis of AS, which we refined to allow for MRI diagnosis of sacroiliitis, and a requirement for a minimum pre-defined movement restriction
  • 2. Fulfil ASAS criteria for axial SpA
  • 3. Aged over 21 years
  • 4. If taking NSAID, have been on a stable dose for at least 4 weeks
  • 5. There was no minimal level of disease activity required for entry to the study

排除标准

  • 1. Any intervention or underlying disease with the potential to effect disease activity or bone density, including treatment with anti-TNF
  • 2. Patients with bilateral hip replacements or previous back surgery that would prevent accurate bone density measurement by dual x-ray absorptiometry (DXA)

研究者

发起方
Royal National Hospital for Rheumatic Diseases (UK)

相似试验